IHM
IOVA icon

Iguana Healthcare Management’s Iovance Biotherapeutics IOVA Stock Holding History

Iguana Healthcare Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$1.69M Buy
+100,000
New +$1.51M 1.11% 36

Other funds holding IOVA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Iguana Healthcare Management's IOVA Position: Q1 2018 in Review

Iguana Healthcare Management opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2018: 100,000 shares worth $1.69M. The stake represents 1.11% of the portfolio and ranks #36 among its holdings.

122 funds tracked by Wall St. Rank hold IOVA as of Q1 2018.

  • Iguana Healthcare Management held 100,000 shares of Iovance Biotherapeutics worth $1.69M as of Q1 2018.
  • Iovance Biotherapeutics was a new Iguana Healthcare Management position in Q1 2018.
  • Iovance Biotherapeutics made up 1.11% of Iguana Healthcare Management's portfolio in Q1 2018, its #36 holding.
  • 122 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.